S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy - Wikidata - awgldk - TriplyDB

S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy

S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy

http://www.wikidata.org/entity/Q35083293

about

Molecular pathogenesis of pulmonary arterial hypertension Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension Microvessel mechanobiology in pulmonary arterial hypertension: cause and effect A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4 Plasma levels of S100A4 in portopulmonary hypertension Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.Idiopathic pulmonary arterial hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies S100A12 mediates aortic wall remodeling and aortic aneurysm.Transcription analysis on response of porcine alveolar macrophages to Haemophilus parasuis.Treating pulmonary arterial hypertension: current treatments and future prospects Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up.Spatiotemporal expression of matrix metalloproteinases (MMPs) is regulated by the Ca2+-signal transducer S100A4 in the pathogenesis of thoracic aortic aneurysm.Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD.Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema.Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension.Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.Pathogenic mechanisms of pulmonary arterial hypertension.Pulmonary arterial remodeling induced by a Th2 immune response Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.Molecular pathogenesis of pulmonary arterial hypertension S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?Signal transduction in the development of pulmonary arterial hypertension Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.Pulmonary hypertension: therapeutic targets within the serotonin system.The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.Endothelin receptor antagonists in preclinical models of pulmonary hypertension.Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall.A process-based review of mouse models of pulmonary hypertension.The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.Experimental and transgenic models of pulmonary hypertension.

P2860

Q24634317-A8932544-A849-46A7-BBF6-412142327B01 Q24814603-5D9C18B2-DD03-4B82-9264-F57BB8578E01 Q27009717-68D93801-5691-4234-B960-83EA8F1F68BE Q27026643-D9DA60B5-CAAF-476D-9324-ABC71C2AFC3A Q27687091-F9FB4FED-99F2-4A1F-8B54-39FB16A1D624 Q33636296-381EC970-2468-4E20-A0A9-BFAAAF977A3C Q33642831-548F8B40-1203-489E-9911-ECB6809DA474 Q33811283-86665F66-495D-49BF-A911-7DB62ADB5A03 Q33815389-6C86126F-4212-440B-B26A-40657CF6B433 Q33849207-95FFBFD4-227F-4BC4-A4D3-491D167ACC26 Q33883852-1FFC849E-B0FE-4962-9FC1-E87475ABF17E Q34157917-3CB2AADA-7ADC-4EC4-B04D-C31021C31C13 Q34318473-B300EFE0-4BF6-45CE-AAE5-6C5A331EED48 Q34524900-D3BF0DC4-3A44-4B1F-AD96-34EF58EED0E0 Q34576091-29592427-11DA-4A3F-9150-1B07A5FD5DD8 Q34782558-F4344E3E-F606-4A17-A0A5-4C5270C1613A Q34905545-84D8B3F1-9C41-44EE-93EB-2400B8DED8F0 Q35168267-9B643272-5CBA-4023-B122-43DFAC6C4303 Q35688158-41377379-B434-4A35-A977-C6CC8B68CEB6 Q35747729-544BC621-54C1-497D-A214-8C552EBCAB1A Q35813870-66A32633-7D9E-42ED-88EE-B0906E03E253 Q35868734-2D7B9E85-1D89-4DD4-A7F2-B567C08D8DB3 Q35916976-DD186EDB-4B75-4A19-8B68-3B2CFCEC2F47 Q35963236-6753E02E-113D-4AC7-872C-647F6552B201 Q35994471-64AF4633-4E09-4E20-A565-A730E12E39FE Q36447388-518984F3-B5FB-4F97-BAB6-D925FA8E263D Q36502869-54772CEB-8F50-4D64-A0C9-5921AD61F7DD Q36701812-73183EA0-7EB7-43BF-B0B0-471F1702EFD1 Q36736065-F12BA900-A137-41A0-BDDC-D5B77617E1B9 Q37103177-990D9F04-F45E-4E09-B364-B92FF27613C0 Q37133785-80E5DB77-07E3-416D-A9AD-932E16B5440F Q37175244-33D76B12-ED6C-4DA9-A4C3-5008B2D9A407 Q37184405-F444FB30-3302-4815-8559-EB16AD67C55C Q37346515-C1C791D2-8106-43A1-BAB3-83854ECBE84D Q37428025-EFCDD1AF-6DB0-43D0-832A-25BF213AB8E0 Q37475033-173CE881-8025-4A9B-8181-EFC5656A040B Q38078369-EBE1E7A0-7208-4C3A-94AD-DA16A89AF940 Q38102555-8F54B1D8-C8A1-42F6-A4A8-CF7409FD375F Q38112038-8EE81B5B-1016-4C4B-9EA9-8B8CB10533DD Q38112056-62300291-9CEF-4904-AE8B-A81ABF2804AD

P2860

S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy

http://www.wikidata.org/entity/Q35083293

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy

@ast

S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy

@en

type

label

S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy

@ast

S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy

@en

prefLabel

S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy

@ast

S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy

@en

P1433

Q35083293-6DFE1D93-C510-486C-80C0-357728AC3710

P1476

Q35083293-2EC12102-47BE-4E18-AE35-0638C983C722

P2093

Q35083293-19797AD8-0571-468F-A874-EC119876B8DD

Q35083293-19827A14-A31E-4A6D-BEED-DEC6711CBEC8

Q35083293-1D391134-E49F-472E-BFA4-5F8B36A3BDD2

Q35083293-384D0516-9757-4446-8BA3-F7C2A09D7457

Q35083293-6CFC95A8-1DBB-498E-AEA4-3C6F5A36F675

Q35083293-B82B7692-A930-4A56-B972-44D23260810B

Q35083293-E8F0BCB9-95E6-4426-91CD-78EE2C76B18D

P2860

Q35083293-248B5C2C-B08D-4748-925B-A4F8419CA0FE

Q35083293-3115B546-D1FC-4265-B428-7C1AC907C4EB

Q35083293-31404F44-AF67-4217-9401-C0E18EE1B3E8

Q35083293-3E3ED220-7511-4B85-9AC4-A80A6666EA21

Q35083293-3E72CCDC-AF79-4724-910F-16BBB9155448

Q35083293-4357C135-CE48-4D79-9A18-45CF9A58F908

Q35083293-438F37A6-BE32-4157-8B28-090E67C01E60

Q35083293-6005AFA3-50B5-45B5-BED8-B677F2A874EC

Q35083293-6287266E-09A2-45C5-8A5F-DAF357ECC787

Q35083293-78BE0E18-00F4-4711-A27B-60F2603EE26F

P304

Q35083293-CEC095F7-67DC-423D-A971-4BBBA0A17BD1

P31

Q35083293-3C9D3884-8BA6-4B06-8150-60B2AA76640B

P356

Q35083293-EB273759-6B71-4406-AEF0-C7AD3B607302

P407

Q35083293-1B9005E3-BF2D-402A-9798-452E1ECC341F

P433

Q35083293-716AF086-C82E-48C3-A129-875C6C106C1F

P478

Q35083293-B4A11ABD-4901-461C-A0E9-2CC1A83D2352

P577

Q35083293-9925807F-90D8-4E3D-9582-167EF2F5F700

P5875

Q35083293-82AE0530-84C4-49FF-803E-527F0D8B8954

P698

Q35083293-11FD9A18-7DBD-44F4-B617-700585268091

P932

Q35083293-77D7CAC3-DB54-4442-AEF4-7BFCE7DA02EE

P356

S0002-9440(10)63115-X

P1433

The American Journal of Pathology

P1476

S100A4/Mts1 produces murine pu ...... human plexogenic arteriopathy

@en

P2093

Edwin Kwan

http://www.w3.org/2001/XMLSchema#string

Eugene Lukanidin

http://www.w3.org/2001/XMLSchema#string

Gideon Du Marchie Sarvaas

http://www.w3.org/2001/XMLSchema#string

Marlene Rabinovitch

http://www.w3.org/2001/XMLSchema#string

Noona Ambartsumian

http://www.w3.org/2001/XMLSchema#string

Robert Jan van Suylen

http://www.w3.org/2001/XMLSchema#string

Steven Greenway

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin

Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth

Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction

The S100 family of EF-hand calcium-binding proteins: functions and pathology

Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

The regulation of vascular smooth muscle cell apoptosis.

Pathobiology of pulmonary hypertension. Extracellular matrix.

Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease.

Ultrastructural findings in lung biopsy material from children with congenital heart defects

P304

253-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63115-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8942958

http://www.w3.org/2001/XMLSchema#string

P698

14695338

http://www.w3.org/2001/XMLSchema#string

P932

1602221

http://www.w3.org/2001/XMLSchema#string